The online version of this article (doi:10.1186/1476-7961-10-8) contains supplementary material, which is available to authorized users.
Ellen B Cook, James L Stahl contributed equally to this work.
The authors declare that there are no competing interests.
EBC conceived of the study, participated in its design, carried out flow cytometry and eosinophil functional studies and analyzed results. JLS participated in the study design, coordination, carried out eosinophil functional studies, and formatted the final version of the manuscript and figures for submission. EAS, KEF carried out RNA and eosinophil functional studies, and analyzed results. SKM conceived of the study and participated in its design. All authors were involved in drafting or critically revising the manuscript and approved the final version.
Thymic stromal lymphopoietin (TSLP) and eosinophils are prominent components of allergic inflammation. Therefore, we sought to determine whether TSLP could activate eosinophils, focusing on measuring the regulation of TSLPR expression on eosinophils and degranulation in response to TSLP, as well as other eosinophil activation responses.
Eosinophil mRNA expression of TSLPR and IL-7Rα was examined by real-time quantitative PCR of human eosinophils treated with TNFα and IL-5 family cytokines, and TSLPR surface expression on eosinophils was analyzed by flow cytometry. Eosinophils were stimulated with TSLP (with and without pre-activation with TNFα and IL-3) and evaluated for release of eosinophil derived neurotoxin (EDN), phosphorylation of STAT5, and survival by trypan blue exclusion. A blocking antibody for TSLPR was used to confirm the specificity of TSLP mediated signaling on eosinophil degranulation.
Eosinophil expression of cell surface TSLPR and TSLPR mRNA was upregulated by stimulation with TNFα and IL-3. TSLP stimulation resulted in release of EDN, phosphorylation of STAT5 as well as promotion of viability and survival. TSLP-stimulated eosinophil degranulation was inhibited by a functional blocking antibody to TSLPR. Pre-activation of eosinophils with TNFα and IL-3 promoted eosinophil degranulation at lower concentrations of TSLP stimulation.
This study demonstrates that eosinophils are activated by TSLP and that eosinophil degranulation in response to TSLP may be enhanced on exposure to cytokines present in allergic inflammation, indicating that the eosinophil has the capacity to participate in TSLP-driven allergic responses.
Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, Waal-Malefyt R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol. 2002, 3: 673-680. 10.1038/nrm910 CrossRefPubMed
Allakhverdi Z, Comeau MR, Jessup HK, Yoon BRP, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G: Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007, 204: 253-258. 10.1084/jem.20062211 PubMedCentralCrossRefPubMed
Reefer AJ, Hulse KE, Lannigan JA, Solga MD, Wright PW, Kelly LA, Patrie J, Chapman MD, Woodfolk JA: Flow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu. J Allergy Clin Immunol. 2010, 126: 1049-1058. 10.1016/j.jaci.2010.07.023 PubMedCentralCrossRefPubMed
Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, Mcallister PK, Busse WW: Comparison of airway and blood eosinophil function after invivo antigen challenge. J Immunol. 1992, 149: 3710-3718. PubMed
Zhu Y, Bertics PJ: Chemoattractant-induced signaling via the Ras−ERK and PI3K−Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5− and IL-3−primed human blood eosinophils. J Immunol. 2011, 186: 516-526. 10.4049/jimmunol.1000955 PubMedCentralCrossRefPubMed
Luijk B, Lindemans CA, Kanters D, van der HR, Bertics P, Lammers JW, Bates ME, Koenderman L: Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J Allergy Clin Immunol. 2005, 115: 997-1003. 10.1016/j.jaci.2005.02.002 CrossRefPubMed
- IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation
Ellen B Cook
James L Stahl
Elizabeth A Schwantes
Kristen E Fox
Sameer K Mathur
- BioMed Central
Neu im Fachgebiet HNO
Mail Icon II